<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>2023</title>
<link href="https://repository.auw.edu.bd/handle/123456789/719" rel="alternate"/>
<subtitle/>
<id>https://repository.auw.edu.bd/handle/123456789/719</id>
<updated>2026-06-09T23:48:11Z</updated>
<dc:date>2026-06-09T23:48:11Z</dc:date>
<entry>
<title>Relationship of Nonsteroidal Anti-Inflammatory Drug Use During Pregnancy with Autism Spectrum Disorder and Intellectual Disability Among Offspring</title>
<link href="https://repository.auw.edu.bd/handle/123456789/867" rel="alternate"/>
<author>
<name>Chowdhury, Mohiuddin Ahsanul Kabir</name>
</author>
<id>https://repository.auw.edu.bd/handle/123456789/867</id>
<updated>2026-02-18T06:15:03Z</updated>
<published>2023-01-01T00:00:00Z</published>
<summary type="text">Relationship of Nonsteroidal Anti-Inflammatory Drug Use During Pregnancy with Autism Spectrum Disorder and Intellectual Disability Among Offspring
Chowdhury, Mohiuddin Ahsanul Kabir
Objective: This study aimed to examine the association of nonsteroidal anti-inflammatory drug (NSAID) use by&#13;
pregnant women during pregnancy with autism spectrum disorder (ASD) and intellectual disability (ID) in their&#13;
children among Medicaid-insured mother–child dyads.&#13;
Materials and Methods: We conducted a retrospective cohort study linking multiple datasets of South Carolina&#13;
for the years between 2010 and 2017, in which the main exposure variable was NSAID use during pregnancy&#13;
and outcome variables were ASD only, ID only, and ASD with ID. We conducted a multinomial logistic&#13;
regression analysis, controlling for identified risk factors for ASD (mother’s age, race, body–mass index,&#13;
preeclampsia, and gestational diabetes).&#13;
Results: NSAID use during pregnancy was found to be associated with ID only in both unadjusted and adjusted&#13;
analyses. Children with mothers who had NSAID prescriptions were 26% more likely to have ID in comparison&#13;
with children whose mothers did not have NSAID prescriptions (odds ratio: 1.26 [1.10–1.46]). The other risk&#13;
factors identified for ASD were maternal age, race, preeclampsia, smoking, low birth weight, and obesity. For&#13;
ID, the risk factors were maternal age, race, smoking, birth weight, overweight, and obesity, all of which were&#13;
also associated with ASD with ID, except for overweight.&#13;
Conclusions: NSAID usage during pregnancy was found to be associated with ID only and not with ASD.&#13;
However, more research is needed to validate the effect of NSAIDs during pregnancy on ASD and ID among&#13;
children.
</summary>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>The Pattern of Sexual Violence among Women and Children in the Hill Tracts of Bangladesh: An Unveiled Truth</title>
<link href="https://repository.auw.edu.bd/handle/123456789/866" rel="alternate"/>
<author>
<name>Chowdhury, Ahsanul Kabir</name>
</author>
<id>https://repository.auw.edu.bd/handle/123456789/866</id>
<updated>2026-02-18T06:15:15Z</updated>
<published>2023-01-01T00:00:00Z</published>
<summary type="text">The Pattern of Sexual Violence among Women and Children in the Hill Tracts of Bangladesh: An Unveiled Truth
Chowdhury, Ahsanul Kabir
Introduction: Gender-based violence (GBV) has emerged as one of the most common and significant social problems worldwide including in Bangladesh. In recent&#13;
&#13;
times, incidents of sexual violence are on a rise in the country. The study was aimed at documenting the patterns of sexual violence that occurred in the hilly hard-&#13;
to-reach areas of Bangladesh.&#13;
&#13;
Methods: This descriptive cross-sectional study was conducted at the Bandarban District Hospital, a secondary-level hospital in one of the hilly districts of&#13;
Bangladesh. The study participants included all the reported sexual assault victims between the period from July 2019 through June 2021. The variables were the&#13;
victim’s age, gender, religion, marital status, occupation, age at menarche, signs of assault, the interval between the incident and reporting, number of perpetrators,&#13;
age of the perpetrators, and relationship of the perpetrator with the victims.&#13;
Results: During the study period, ninety cases were reported in selected hospitals of whom 86 (95.6%) were female and the rest (4.4%) were male. The mean age&#13;
of the victims was 16±6.9 years (range: 2-40 years). Most of the victims (61.4%) were from the age group 11-20 years while 18.2% were below 10 years. Less than&#13;
half (44.4%) of victims were assaulted before menarche. About 25% of the incidents took place in Farmhouses, or areas close to the forest or springs, while 34.4%&#13;
occurred in either the victim’s or the perpetrator’s house. In most of the instances (75.6%), the number of perpetrators was single, and the mean age of them was&#13;
22.5±6.3 years (range: 13-45 years). In about 40% of cases, the perpetrator was known to the victim personally. Among 90 victims, 15(16.6%) were assaulted by&#13;
their present or ex-lovers.&#13;
Conclusion: This study would help to set up the platform to undergo more research in this neglected, yet important area related to human rights violations.
</summary>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019</title>
<link href="https://repository.auw.edu.bd/handle/123456789/865" rel="alternate"/>
<author>
<name/>
</author>
<id>https://repository.auw.edu.bd/handle/123456789/865</id>
<updated>2026-02-18T06:15:31Z</updated>
<published>2023-01-01T00:00:00Z</published>
<summary type="text">Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
Background: Asthma and atopic dermatitis (AD) are chronic allergic conditions, along with&#13;
allergic rhinitis and food allergy and cause high morbidity and mortality both in children and&#13;
adults. This study aims to evaluate the global, regional, national and temporal trends of the&#13;
burden of asthma and AD from 1990 to 2019 and analyze their associations with geographic,&#13;
demographic, social, and clinical factors.&#13;
Methods: Using data from the Global Burden of Diseases (GBD), Injuries, and Risk Factors&#13;
&#13;
Study 2019, we assessed the age-standardized prevalence, incidence, mortality, and disability-&#13;
adjusted life years (DALYs) of both asthma and AD from 1990 to 2019, stratified by geographic&#13;
&#13;
region, age, sex, and socio-demographic index (SDI). DALYs were calculated as the sum of&#13;
years lived with disability and years of life lost to premature mortality. Additionally, the disease&#13;
burden of asthma attributable to high body mass index, occupational asthmagens, and smoking&#13;
was described.&#13;
Results: In 2019, there were a total of 262 million [95% UI: 224–309 million] cases of&#13;
asthma and 171 million [95% UI: 165–178 million] total cases of AD globally; age-standardized&#13;
prevalence rates were 3,416 [95% UI: 2,899–4,066] and 2,277 [95% UI: 2,192–2,369] per 100,000&#13;
population for asthma and AD, respectively, a 24.1% [95% UI: −27.2 to −20.8] decrease for&#13;
asthma and a 4.3% [95% UI: 3.8–4.8] decrease for AD compared to baseline in 1990. Both asthma&#13;
and AD had similar trends according to age, with age-specific prevalence rates peaking at age&#13;
5–9 years and rising again in adulthood. The prevalence and incidence of asthma and AD were&#13;
both higher for individuals with higher SDI; however, mortality and DALYs rates of individuals&#13;
with asthma had a reverse trend, with higher mortality and DALYs rates in those in the lower SDI&#13;
quintiles. Of the three risk factors, high body mass index contributed to the highest DALYs and&#13;
deaths due to asthma, accounting for a total of 3.65 million [95% UI: 2.14–5.60 million] asthma&#13;
DALYs and 75,377 [95% UI: 40,615–122,841] asthma deaths.&#13;
Conclusions: Asthma and AD continue to cause significant morbidity worldwide, having&#13;
&#13;
increased in total prevalence and incidence cases worldwide, but having decreased in age-&#13;
standardized prevalence rates from 1990 to 2019. Although both are more frequent at younger&#13;
&#13;
ages and more prevalent in high-SDI countries, each condition has distinct temporal and regional&#13;
characteristics. Understanding the temporospatial trends in the disease burden of asthma and AD&#13;
could guide future policies and interventions to better manage these diseases worldwide and&#13;
achieve equity in prevention, diagnosis and treatment.
</summary>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</entry>
</feed>
